On September 1st, The launch of National Key R&D Program of China, Precision medicine project, "the development of ultra-sensitive and high-coverage technologies for quantitative metabolomics utilized in the clinic" was held in DICP.
The project leader, Prof. XU Guowang and the principal investigators from East China University of Science and Technology, Kunming Institute of Botany, CAS, Tsinghua University, the 6th hospital of Shanghai Jiao Tong University and Eastern Hepatobiliary Surgery Hospital attended the meeting.
The attendees studied the project and financial management of National Key R&D Program of China. The schedule for the tasks of each group was confirmed. The exchange and discussion mechanism was planned among the groups of the projects. And the cooperation among the groups was also coordinated during the meeting, which provided a good beginning of the project.
The project, "the development of ultra-sensitive and high-coverage technologies for quantitative metabolomics utilized in the clinic" collected multidisciplinary teams of metabolomics and related subjects in China. And the project aims to develop novel systemic techniques including chromatography-mass spectrometry, nuclear magnetic resonance, fluorescent probes and microfluidic chip, achieves ultra-sensitive, high-coverage, real time and in-situ measurements of metabolome in biological samples.
The developed techniques will be applied to the clinical studies of hepatocellular carcinoma and diabetes, provide support for diagnosis, sub-typing and treatment of diseases. (Text by YIN Peiyuan and Image by HOU Xiaoli)
